Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seq_finder
    Junior Member
    • Nov 2013
    • 1

    #1

    Replicates correlation for differential expression

    I have miRNA seq experiment with two conditions; (i) Asthma patients (treatments) and (ii) normal (controls). There are 9 human patients and 6 normal human that I am using as replicates for differential expression analysis by DESeq. I found following miRNAs count.

    Treatments [/B]
    Replicates : miRNA expressed
    T_R_1 : 581
    T_R_2 : 617
    T_R_3 : 618
    T_R_4 : 591
    T_R_5 : 573
    T_R_6 : 585
    T_R_7 : 602
    T_R_8 : 568
    T_R_9 : 633

    Controls[/B]
    Replicates : miRNA expressed
    C_R_1 : 587
    C_R_2 : 560
    C_R_3 : 423
    C_R_4 : 572
    C_R_5 : 550
    C_R_6 : 535

    After performing differential expression by DESeq only 42 miRNAs are significant at pval <=0.05 and fold change ±1.5. To understand the correlation between replicates I created correlation heatmap (attached) and found strange correlation. I would like to know that with this correlation the 42 miRNAs that are differentially expressed is a good result or a bad result? Waiting for a positive response, thanks in advance.
    Attached Files
    Last edited by seq_finder; 11-22-2013, 07:44 AM.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    1. I hope that by pval <= 0.05 you actually mean adjusted p-value < 0.1 (<0.05, not <=0.05, is common for unadjusted p-values).
    2. This isn't the 90s, you don't need artificial fold-change cutoffs. Yes, you probably want to prioritize things by fold-change, but the biologically significant minimal fold-change is gene (and context) dependent.
    3. DESeq or DESeq2? If DESeq, try DESeq2, it's more powerful.
    4. How were the correlations determined? As in the DESeq vignette or did you code something up yourself?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...